Crossmark

Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study)

Crossref DOI link: https://doi.org/10.1186/s12888-017-1393-0

Published Online: 2017-06-26

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Marwood, L. https://orcid.org/0000-0002-5818-2199
Taylor, R.

Goldsmith, K.

Romeo, R.

Holland, R.

Pickles, A.

Hutchinson, J.

Dietch, D.

Cipriani, A.

Nair, R.

Attenburrow, M.-J.

Young, A. H.

Geddes, J.

McAllister-Williams, R. H.

Cleare, A. J.
Funding

Funding for this research was provided by:

Health Technology Assessment Programme (GB) (14/222/02)

Document is current

Any future updates will be listed below